Seasoned director with almost twenty years in the industry, Alberto Bresciani’s experience ranges from early drug discovery projects to later development stages, including clinical trials.
Dr. Bresciani has led and/or actively collaborated in multiple drug discovery projects spanning multiple therapeutic areas (e.g. infectious diseases, oncology, CNS) and modalities (e.g. small molecules, siRNA/ASO, splicing modulators).
At Exscientia, Dr. Bresciani’s remit is leading programmes in antiviral space(e.g. influenza, Coronavirus, paramyxovirus) and supporting projects in the anti-infective area (e.g. malaria, tuberculosis).